Test Price
2,800 AED✅ Home Collection Available
SLC24A5 Gene Oculocutaneous Albinism Nonsyndromic Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين SLC24A5 للابيضاض الجلدي العيني غير المتلازمي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary (ملخص تنفيذي)
- ✔ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
- ✔ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM daily).
- ✔ Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation by DHA-licensed genetic experts.
- ✔ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- دقة تشخيصية مضمونة وتوجيه طبي بعد الفحص، مع سحب منزلي متوافق مع أعلى معايير النقل المبرد.
Overview
This comprehensive Next-Generation Sequencing (NGS) test analyzes the entire SLC24A5 gene to diagnose oculocutaneous albinism type 6 (OCA6), guiding dermatological, ophthalmological, and oncological surveillance for individuals and families at risk. يُحلل هذا الاختبار الجيني الشامل جين SLC24A5 بالكامل لتشخيص الابيضاض الجلدي العيني النوع 6، مما يوجه المتابعة الطبية متعددة التخصصات.
| Feature | Our NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity for all mutation types (point, indels, CNVs) | ~80% for known variants only; novel variants often missed |
| Methodology | NGS (Illumina® NovaSeq™), ISO 9001:2015 compliant | Sanger dideoxy method, limited to pre-defined regions |
| Turnaround Time | 3 to 4 Weeks | 5 to 8 Weeks |
| DHA/MOHAP Recognition | Full regulatory compliance (License 9834453) | Variable; often outsourced |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA: 61713011), Clinical Geneticist: "I recognize that a genetic diagnosis of albinism carries profound emotional and medical implications; this test offers clarity for informed decision‑making. My team ensures you understand that results must be correlated with clinical examination by a specialist. Please never discontinue prescribed medications or protective sun‑avoidance measures without consulting your doctor."
⚠ Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Safety Exclusion Criteria & ER Red Flags
- Exclusion Criteria: Inability to provide informed consent; uncooperative patient for blood draw; sample contamination or degradation risk. No acute illness contraindication, but reschedule if high fever.
- Emergency Red Flags (seek urgent care): Rapidly changing skin lesion, severe sunburn with blistering, sudden vision loss, or signs of skin infection after sample collection.
- Children & Minors: Parent/guardian must be present; strict compliance with UAE Child Data Sovereignty Law (CDS Law 2026) and Federal Decree‑Law No. 41 of 2024 Art. 87.
Patient FAQ & Clinical Guidance
What is the SLC24A5 gene test and why do I need it?
The SLC24A5 gene test is a next‑generation sequencing analysis that identifies all mutation types causing oculocutaneous albinism type 6, providing definitive diagnosis and risk assessment for skin and eye complications. It is indicated for individuals with pigment dilution, nystagmus, photophobia, or a family history of albinism. Early diagnosis enables sun protection, vision care, and skin cancer surveillance.
يقوم اختبار جين SLC24A5 بتحليل كامل الجين لكشف الطفرات المسببة للابيضاض الجلدي العيني النوع 6، مما يوفر تشخيصاً دقيقاً وتقييماً للمخاطر الجلدية والبصرية.
How do I prepare for the test and what sample is collected?
You must attend a pre‑test genetic counselling session to draw a detailed pedigree chart; sample collection is via a simple blood draw, dried blood spot, or extracted DNA by our DHA‑licensed mobile phlebotomist at your home or office. No fasting is required. Please continue all medications unless your doctor advises otherwise. Our team arrives with ISO‑certified cold‑chain transport kits to maintain sample integrity.
تحتاج إلى جلسة استشارة وراثية مسبقة لرسم شجرة العائلة؛ ويتم جمع العينة عن طريق سحب الدم المنزلي أو بقعة الدم المجففة بواسطة أخصائي سحب مرخص من هيئة الصحة بدبي.
What do my results mean and what are the next steps after a positive result?
A positive result confirms an SLC24A5 mutation associated with OCA6, requiring lifelong multidisciplinary care from dermatology, ophthalmology, and oncology to manage sun protection, vision aids, and skin checks. A negative result reduces but does not eliminate risk; clinical correlation remains essential. Our post‑ tele‑guidance helps you coordinate with UAE specialists.
النتيجة الإيجابية تؤكد وجود طفرة جينية مرتبطة بالابيضاض الجلدي العيني النوع 6، وتستدعي متابعة متعددة الاختصاصات تشمل الأمراض الجلدية والعيون والأورام.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians